Konstantin Matentzoglu

Konstantin Matentzoglu is an accomplished professional in the biotechnology and pharmaceuticals sector, currently serving as a Member of the Supervisory Board at Polpharma Biologics and BSP Pharmaceuticals S.p.A., and as a Partner at CDL Therapeutics GmbH and PREDICTION BIOSCIENCES. Previous roles include CEO and Member of the Supervisory Board at Celonic Group, and Partner at Trenzyme GmbH. Konstantin Matentzoglu holds a promotion in biochemistry from the University of Konstanz and has a Diplom in biology from Universität Köln. Further educational experiences include studies at NKI Amsterdam and LCBS.